Women in Immunology

New for 2020, as part of our Immuno Series we are delighted to announce the Women in Immunology symposium. This session is designed to provide a platform for female speakers to share their research and experience, highlighting the ground-breaking work being completed by women in immunology.

Confirmed Speakers

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for the 2020 Series.

Alex Cao
Executive Director, Head of Clinical Biomarkers, Translational Oncology
MSD
Ali Mohamed
Vice President, CMC
Immatics
Ali Roghanian
Lecturer in Cancer Immunotherapy
University of Southampton
Andreas Frei
Discovery Scientist
F. Hoffmann-La Roche Ltd
Andreas Loew
Chief Scientific Officer
Elstar Therapeutics
Andrew Exley
Medical Assessor, Biologicals and Biotechnology Unit
MHRA
Andrew Godkin
Professor
Cardiff University
Barbara Joyce-Shaikh
Associate Principal Scientist
MSD
Bjorn Frendeus
Chief Scientific Officer
BioInvent International
Brian Champion
Chief Scientific Officer
PsiOxus Therapeutics
Bryan Glaser
Vice President of Business Development
Invenra
Celine Adessi
Senior Director, Group Head, Oncology, Clinical Safety
F. Hoffmann-La Roche Ltd
Christopher Harvey
Director of Preclinical Sciences and JTX-2011 Scientific Lead
Jounce Therapeutics
Dan Blat
Group Leader, Preclinical Biology
Immunocore
Dario Ruscica
Director, Study Physician Immuno-Oncology R&D
AstraZeneca
David Dornan
Senior Vice President and Head of Research
Bolt Bio
David Wraith
Professor of Immunology
Institute of Immunolgy & Immunology
Dorothee Bourges
Lab Head Pharmacology/Immuno-Oncology
Sanofi
Douglas Jolly
Executive Vice President Research & Pharmaceutical Development
Tocagen
Douglas Widman
Associate Director of R&D Program Management
Karyopharm Therapeutics Inc.
Elena Menietti
Scientist
F. Hoffmann-La Roche Ltd
Eleni Vritzali
Medical Director, Global Development Immunology and Transplantation
Novartis
Erik Hett
Head of Experimental and Chemical Biology
Merck
Farhat Syed
Associate Director Precision Medicine
AstraZeneca
Frederic Triebel
Chief Scientific Officer & Chief Medical Officer
Immutep
Geert Mudde
Chief Scientific Officer & Founder
OncoQR ML, S-TARget Therapeutics GmbH and TYG Oncology Ltd.
Guido Wollmann
Chief Scientific Officer
Immutep
Hyewon Phee
Senior Scientist in Dept of Inflam/Onco
Amgen
Igor Proscurshim
Medical Director
Takeda
James Legg
Senior Vice President Research
Crescendo Biologics
Jean-Jacques Mention
Head of Scientific Business Development in Immuno-Oncology and Auto-Immune Diseases
OSE Immunotherapeutics
Jens Kringelum
Director Genomic Immuno-Oncology
Evaxion Biotech
Jerome Zeldis
Chief Medical Officer and President of Clinical Development, Regulatory, Drug Safety, Quality and Medical Affairs
Sorrento Therapeutics
Jochen Strizker
Senior Vice President Immunotherapy
Themis Bioscience GmbH
John Maher
Professor
King's College London
Jonathan Pachter
Chief Scientific Officer
Verastem
Laure Twyffels
R&D Senior Scientist
Celyad
Lindy Durrant
Chief Scientific Officer
Scancell
Lorena Lerner
Vice President Molecular Biology and Virology
Oncorus
Lucia Kucerova
Senior Research Manager
Glycostem
Mahendra Deonarain
Chief Executive and Science Officer, Director of R&D
Antikor
Marc van Dijk
Vice President Platform Technology
AgenTus Therapeutics
Marek Stastny
Senior Scientific Advisor
Bristol-Myers Squibb
Maria Amann
Principal Scientist
F. Hoffmann-La Roche Ltd
Mario Ehlers
Executive Director, Head of Early Clinical Development, Immunology
Boehringer Ingelheim
Masha Poyurovsky
Vice President, Discovery Biology
Kadmon Research Institute
Matthew Robinson
Vice President Translational Biology
Microbiotica
Matthew Sleeman
Executive Director, Immunology & Inflammation
Regeneron Pharmaceuticals
Nehal Mehta
Section of Inflammation and Cardiometabolic Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Omid Vafa
Chief Business Officer
Teneo Bio
Pakeeza Sayyed
Principal Clinical Scientist
F. Hoffmann-La Roche Ltd
Partha Chowdhury
Senior Director and Fellow
Sanofi
Pelin Candarlioglu
Investigator - Bioengineer/Cell Biologist
GlaxoSmithKline
Peter Weber
Director
Immunocore
Rajita Pappu
Senior Scientist, Immunology Discovery
Genentech
Richard Sainson
Senior Director, Translational Medicine
Kymab
Richard Tavare
Staff Scientist
Regeneron Pharmaceuticals
Rodolfo Chaparro
Head of Immunology
CUE BioPharm
Roman Kischel
Director
Amgen
Russell LaMontagne
Chief Executive Officer
Boston Immune Technologies and Therapeutics
Sari Pesonen
Head of R&D
Valo Therapeutics
Saso Cemerski
Senior Director, Translational Immunology
CUE BioPharm
Shahram Lavasani
President & Chief Executive Officer
Immune Bio AB
Shruthi Bharadwaj
Senior Scientist, Oncology Precision Medicine
Novartis
Sonia Feau
Associate Director Immunology
Oncorus
Sonya Abraham
Medical Director, Head New Treatment Strategies Immunology
UCB
Stefanie Urlinger
Vice President Antibody Development
iOmx Therapeutics
Steven Grant
Manager, Biopharm Molecular Discovery
GlaxoSmithKline
Tauseef Butt
President & Chief Executive Officer
Progenra

Download Brochure

Full details regarding the Immuno Series UK are available for download in the Conference Brochure

Calling all Immunologists!

With a key priority in the IO industry centring around developing effective combination therapies, we are currently preparing a detailed market survey to provide the community with insights from leading experts into their strategies for this, the technologies they require and any bottlenecks.

Have your say in our Immuno-Oncology Market Survey & win an iPad Mini 4!